Short Interest in Moolec Science SA (NASDAQ:MLECW) Decreases By 64.0%

Moolec Science SA (NASDAQ:MLECW) was the recipient of a large decline in short interest in February. As of February 27th, there was short interest totaling 11,029 shares, a decline of 64.0% from the February 12th total of 30,636 shares. Based on an average trading volume of 2,446,965 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 2,446,965 shares, the short-interest ratio is presently 0.0 days.

Moolec Science Stock Performance

Shares of MLECW traded up $0.00 during trading hours on Thursday, hitting $0.03. 305,829 shares of the company were exchanged, compared to its average volume of 1,087,053. Moolec Science has a fifty-two week low of $0.00 and a fifty-two week high of $0.16. The firm’s fifty day moving average is $0.02 and its 200 day moving average is $0.01.

Moolec Science Company Profile

Moolec Science is a biotechnology company focused on developing gene-edited livestock as living bioreactors to produce therapeutic proteins. The company leverages CRISPR/Cas9 and related gene-editing technologies to introduce human genes into the genome of pigs, enabling the secretion of complex human proteins in sow’s milk. By combining advanced genetic engineering with traditional livestock breeding, Moolec Science aims to address scalability and cost challenges associated with conventional biologics manufacturing.

The company’s pipeline centers on the production of large multimolecular proteins, including coagulation factors and antibody fragments, for rare diseases and life-threatening conditions.